Malnutrition Associated With Complications After Ileostomy Reversal
Postoperative Complications in Patients With Inflammatory Bowel Disease: A Retrospective Cohort Study
1 other identifier
observational
359
1 country
1
Brief Summary
An ileostomy is a surgical opening established by bringing the end or a loop of the ileum to discharge directly outside the body. This is typically done when part or the entire colon is removed because of IBD, cancer, or familial adenomatous polyposis. Reversal of this procedure, an ileostomy closure, may be done if possible. Ileostomy closure involves reconnecting the ileum to the remaining colon, allowing normal bowel movements again. This study will look at the outcomes of these surgeries in patients who were seen and operated on by the investigators.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2015
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 5, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 5, 2018
CompletedFirst Submitted
Initial submission to the registry
April 8, 2019
CompletedFirst Posted
Study publicly available on registry
April 10, 2019
CompletedApril 10, 2019
April 1, 2019
3 years
April 8, 2019
April 8, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Complications
Number of any post operative complication
up to 5 years
Study Arms (1)
Ileostomy Closure
Patients who have undergone an ileostomy closure procedure.
Eligibility Criteria
Patients who have had an ileostomy closure procedure
You may qualify if:
- ileostomy closure procedure
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joel J Bauer, MD
Icahn School of Medicine at Mount Sinai
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Joel J Bauer MD, Professor of Surgery
Study Record Dates
First Submitted
April 8, 2019
First Posted
April 10, 2019
Study Start
March 1, 2015
Primary Completion
March 5, 2018
Study Completion
March 5, 2018
Last Updated
April 10, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share